Edition:
United Kingdom

Alexion Pharmaceuticals Inc (ALXN.O)

ALXN.O on Nasdaq

115.33USD
23 Aug 2019
Change (% chg)

$-0.00 (-0.00%)
Prev Close
$115.33
Open
$123.12
Day's High
$124.02
Day's Low
$114.93
Volume
5,246,754
Avg. Vol
1,769,724
52-wk High
$141.86
52-wk Low
$92.56

About

Alexion Pharmaceuticals, Inc. is a biopharmaceutical company. The Company is focused on the development and commercialization of therapeutic products. The Company's products include Soliris (eculizumab), Strensiq (asfotase alfa) and Kanuma (sebelipase alfa). The Company's clinical development programs include Soliris (eculizumab... (more)

Overall

Beta: 1.28
Market Cap(Mil.): $31,536.07
Shares Outstanding(Mil.): 223.19
Dividend: --
Yield (%): --

Financials

  ALXN.O Industry Sector
P/E (TTM): 61.23 29.89 32.67
EPS (TTM): 2.31 -- --
ROI: 4.17 14.89 14.48
ROE: 6.11 16.01 15.78

Drugmakers Jazz, Alexion, Lundbeck to pay $123 million to resolve U.S. charity kickback probe

BOSTON Three drugmakers will pay $122.6 million to resolve claims they used charities that help cover Medicare patients' out-of-pocket drug costs as a way to pay kickbacks aimed at encouraging use of their medications, including some expensive ones.

04 Apr 2019

UPDATE 3-Drugmakers Jazz, Alexion, Lundbeck to pay $123 mln to resolve U.S. charity kickback probe

BOSTON, April 4 Three drugmakers will pay $122.6 million to resolve claims they used charities that help cover Medicare patients' out-of-pocket drug costs as a way to pay kickbacks aimed at encouraging use of their medications, including some expensive ones.

04 Apr 2019
Reuters.com is improving our Quote page. Click here to take a look and let us know what you think.

Earnings vs. Estimates